Ortopedyczno-Rehabilitacyjny Szpital Kliniczny Im Wiktora Degi Uniwersytetu Medycznego Im Karola Marcinkowskiego W Poznaniu — Clinical Trial Site

12 Registered trials

5 Currently recruiting

Organisation

Ortopedyczno-Rehabilitacyjny Szpital Kliniczny Im Wiktora Degi Uniwersytetu Medycznego Im Karola Marcinkowskiego W Poznaniu

Location

Poznan, Poland

Identifier

ORG-100044930

Address

Ul. 28 Czerwca 1956 R. 135/147, 61-544, Poland

Departments

#40484:Klinika Reumatologii, Rehabilitacji i Chorob Wewnetrznych
3352: Oddział Reumatologii, Rehabilitacji i Chorób Wewnętrznych
40484: Klinika Reumatologii, Rehabilitacji i Chorob Wewnetrznych
616004:Klinika Ortopedii i Traumatologii - Oddział Urazowo - Ortopedyczny, Alloplastyki Stawów Bio
Klinika Reumatologii, Rehabilitacji i Chorób Wewnętrznych
Oddzial Reumatologii, Rehabilitacji i Chorob Wewnetrznych
Oddział Reumatologii, Rehabilitacji i Chorób Wewnetrznych

Clinical trials at this site (12)

Search interface

Efficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active SLE (POETYK SLE-2) Recruiting

2022-500700-22-00 Active Systemic Lupus Erythematosus (SLE) 5 2023-05-25
REGN7508 versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults. Recruiting

2025-520478-20-00 Thromboembolic disease 5 2025-11-05
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared … Recruiting

2023-504022-19-01 Polymyositis or dermatomyositis according to 2017 EULAR 5 2024-12-13
A clinical trial to learn about the effects of YTB323 in people with difficult to treat severe diffuse cutaneous systemic sclerosis (dcSSc) Recruiting

2023-510380-34-00 Diffuse cutaneous systemic sclerosis (dcSSc) 4 2024-12-10
A study to learn if dapirolizumab pegol works and is safe in people with moderately to severely active systemic lupus erythematosus (SLE) Recruiting

2023-508191-11-00 Systemic lupus erythematosus (SLE) 5 2024-11-28
A research study to evaluate the efficacy and safety of cenerimod in subjects suffering from systemic lupus erythematosus Ended

2024-515871-37-00 Moderate to severe systemic lupus erythematosus 5 2024-10-24
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic … Ended

2023-503655-10-00 Systemic Lupus Erythematosus (SLE). 5 2023-11-20
Phase 3 Study of Anifrolumab in Adult Patients with Active Proliferative Lupus Nephritis Ended

2023-506359-68-00 Active Proliferative Lupus Nephritis 5 2022-04-08
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Patients with Systemic Lupus Erythematosus (ALLEGORY) Ended

2023-504774-38-00 Systemic Lupus Erythematosus (SLE) 5 2021-11-04
A study to learn if dapirolizumab pegol is safe and works long-term in people with systemic lupus erythematosus Ended

2023-506368-14-00 Systemic lupus erythematosus (SLE) 5 2021-09-07
A study to learn how well bimekizumab works and how safe it is in adults with psoriatic arthritis Ended

2024-511738-11-00 Psoriatic arthritis 5 2024-12-18
A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis Ended

2023-509782-20-00 Diffuse Cutaneous Systemic Sclerosis 4 2021-11-11